334 completed, 49 unknown, 21 terminated, 15 recruiting. 188 Phase 1, 92 Phase 3, 90 Phase 4, 54 Phase 2, 23 Not applicable.
Follow Rosuvastatin: new trials by email Literature Review of Rosuvastatin trials Research Report on Rosuvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012) Midazolam, Rosuvastatin, MK-6916 - Healthy | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 18 | 2026-11-30 | 2026-10-07 |
| A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol Dabigatran Etexilate, Rosuvastatin, CHF10196 - Healthy Male Volunteers | Phase 1 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | 24 | 2026-10-27 | 2026-08-04 |
| An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition Rilzabrutinib, Rosuvastatin, Digoxin - Healthy Volunteer | Phase 1 | Active not recruiting | Sanofi | 14 | 2026-10-01 | 2026-10-21 |
| A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Bempedoic acid, Ezetimibe, Rosuvastatin - Coronary Atherosclerosis, Mixed Dyslipidemia | Phase 3 | Not yet recruiting | Daiichi Sankyo | 103 | 2026-09-30 | 2026-09-29 |
| A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395 BGB-43395, Midazolam, Celecoxib - Healthy Adult Participants | Phase 1 | Recruiting | BeOne Medicines | 24 | 2026-09-25 | 2026-10-23 |
| A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007) Rosuvastatin, MK-4646 - Healthy | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 16 | 2026-09-25 | 2026-10-05 |
| Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial Rosuvastatin, Ezetimibe, Recaticimab - Intracranial Arteriosclerosis, Cognitive Impairment | Phase 4 | Not yet recruiting | Peking Union Medical College Hospital | 440 | 2026-09-17 | 2026-09-15 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults Itraconazole, Rifampicin, Omeprazole - Healthy Subjects | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | 60 | 2026-09-16 | 2026-10-15 |
| Rosuvastatin and Losartan Pharmacokinetics After Bariatric Surgery Rosuvastatin, Losartan (Control) - Obesity & Overweight, Bariatric Surgery | Not applicable | Not yet recruiting | Hospital das Clínicas de Ribeirão Preto | 60 | 2026-08-02 | 2026-08-05 |
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants BMS-986533, Famotidine, Placebo - Healthy Volunteers | Phase 1 | Recruiting | Bristol-Myers Squibb | 136 | 2026-07-13 | 2026-07-24 |
| Statins to Prevent Cancer Associated Blood Clots Rosuvastatin, Placebo Drug - Venous Thromboembolism, Cancer | Phase 4 | Recruiting | Brigham and Women's Hospital | 4000 | 2026-06-11 | 2026-09-16 |
| Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Pitavastatin/ezetimibe, Atorvastatin or Rosuvastatin - Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | Not applicable | Not yet recruiting | Samsung Medical Center | 5000 | 2026-06-01 | 2026-06-10 |
| A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants Elecoglipron, Atorvastatin, Rosuvastatin - Healthy Participants | Phase 1 | Active not recruiting | AstraZeneca | 48 | 2026-04-16 | 2026-08-28 |
| A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults Nurandociguat, Rosuvastatin, Dabigatran etexilate - Chronic Kidney Disease | Phase 1 | Withdrawn | Bayer | 2026-04-08 | 2026-05-12 | |
| A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together Repinatrabit, EE/NE, Metformin - Healthy Volunteers | Phase 1 | Recruiting | Otsuka Pharmaceutical Development & Commercialization, Inc. | 48 | 2026-03-31 | 2026-08-12 |
| A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005) Rosuvastatin, Furosemide, MK-2828 - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 41 | 2026-03-18 | 2026-09-08 |
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | 60 | 2026-03-12 | 2026-05-06 |
| Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers Simvastatin (10mg, 20mg, 40mg), Rosuvastatin (5mg, 20mg, 40mg), Atorvastatin (10mg, 20mg, 40mg) - Diabete Mellitus, Lipid Profile | Phase 1 | Not yet recruiting | Shaheed Benazir Bhutto University Sheringal Dir Upper | 100 | 2026-03-01 | 2026-01-30 |
| The Effects of Rosuvastatin on Running Training Adaptation and Safety Rosuvastatin - Dyslipidemia, Long-Distance Running | Not applicable | Not yet recruiting | Taipei Medical University WanFang Hospital | 40 | 2026-03-01 | 2026-02-10 |
| A Study of LY4515100 in Healthy Participants LY4515100 via SAD, LY4515100 via MAD, LY4515100 - Healthy | Phase 1 | Recruiting | Eli Lilly and Company | 123 | 2026-01-15 | 2026-07-29 |
Showing 20 of 449. Sign in to see all of them.
Hypercholesterolemia (63) · Dyslipidemias (36) · Coronary Artery Disease (23) · Hypertension (21) · Atherosclerosis (20) · Diabetes Mellitus (20) · Hyperlipidemias (20) · Acute Coronary Syndrome (13) · Cardiovascular Diseases (13) · Diabetes Mellitus, Type 2 (12) · Stroke (12) · Coronary Disease (9) · Inflammation (9) · Obesity (8) · HIV Infections (7)
AstraZeneca (67) · Boehringer Ingelheim (12) · Pfizer (11) · Bristol-Myers Squibb (10) · Eli Lilly and Company (10) · Sanofi (8) · Alvogen Korea (7) · Merck Sharp & Dohme LLC (7) · Bayer (6) · Boryung Pharmaceutical Co., Ltd (6) · Organon and Co (6) · Radboud University Medical Center (6) · Daiichi Sankyo (4) · Enanta Pharmaceuticals, Inc (4) · GlaxoSmithKline (4)
United States (136) · South Korea (46) · China (39) · Canada (35) · Germany (35) · United Kingdom (26) · Netherlands (25) · Italy (24) · Mexico (18) · Spain (17) · France (16) · Belgium (15) · Norway (15) · Taiwan (14) · Australia (13)
Russell Esterline (11) · Anna Toso, MD (2) · Annapoorna Kini, MD (2)
PMID 38018702, PMID 19359665, PMID 21174145, PMID 21518985, PMID 25269777, PMID 25660356, PMID 27777279, PMID 30183102, PMID 34298554, PMID 37565307, PMID 12719282, PMID 12917318, PMID 14736433, PMID 15277322, PMID 15308692, PMID 15320751, PMID 15324521, PMID 15353511, PMID 15500430, PMID 15708716, PMID 15894785, PMID 16134130, PMID 16579514, PMID 17276178, PMID 17298834, PMID 17416370, PMID 17452537, PMID 17936040, PMID 17975198, PMID 18018771, PMID 18196620, PMID 18347202, PMID 18413499, PMID 18452788, PMID 18509206, PMID 18535816, PMID 18539753, PMID 18584016, PMID 18702965, PMID 18706705, PMID 18757089, PMID 18757090, PMID 18783301, PMID 18996523, PMID 18997196, PMID 19101028, PMID 19197830, PMID 19249441, PMID 19329177, PMID 19329822
2019 (6), 2015 (5), 2025 (4), 2017 (3), 2005 (2), 2004 (1), 2008 (1), 2009 (1), 2014 (1), 2016 (1), 2018 (1), 2023 (1), K23HL143161 (1), N01HR056179 (1), R01GM078501 (1)